Smith SM - Search Results

1

Antipsychotics and hyperprolactinaemia: clinical recommendations.

Peveler RC, Branford D, Citrome L, Fitzgerald P, Harvey PW, Holt RI, Howard L, Kohen D, Jones I, O'Keane V, Pariente CM, Pendlebury J, Smith SM, Yeomans D. Peveler RC, et al. Among authors: smith sm. J Psychopharmacol. 2008 Mar;22(2 Suppl):98-103. doi: 10.1177/0269881107087346. J Psychopharmacol. 2008. PMID: 18477626 Review.

2

The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis.

Smith S, Wheeler MJ, Murray R, O'Keane V. Smith S, et al. J Clin Psychopharmacol. 2002 Apr;22(2):109-14. doi: 10.1097/00004714-200204000-00002. J Clin Psychopharmacol. 2002. PMID: 11910254

3

Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice.

Smith S. Smith S. J Clin Psychopharmacol. 2003 Jun;23(3 Suppl 1):S27-32. doi: 10.1097/01.jcp.0000084035.22282.31. J Clin Psychopharmacol. 2003. PMID: 12832947 Review.

4

Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment.

Howes OD, Wheeler MJ, Meaney AM, O'Keane V, Fogelman I, Blake G, Murray RM, Smith S. Howes OD, et al. J Clin Psychopharmacol. 2005 Jun;25(3):259-61. doi: 10.1097/01.jcp.0000162798.87249.4d. J Clin Psychopharmacol. 2005. PMID: 15876906 Free PMC article.

5

A well-being programme in severe mental illness. Reducing risk for physical ill-health: a post-programme service evaluation at 2 years.

Smith S, Yeomans D, Bushe CJ, Eriksson C, Harrison T, Holmes R, Mynors-Wallis L, Oatway H, Sullivan G. Smith S, et al. Eur Psychiatry. 2007 Oct;22(7):413-8. doi: 10.1016/j.eurpsy.2007.07.002. Epub 2007 Aug 31. Eur Psychiatry. 2007. PMID: 17765483

6

Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics.

Bushe C, Yeomans D, Floyd T, Smith SM. Bushe C, et al. Among authors: smith sm. J Psychopharmacol. 2008 Mar;22(2 Suppl):56-62. doi: 10.1177/0269881107088436. J Psychopharmacol. 2008. PMID: 18477621

7

The impact of hyperprolactinaemia on sexual function in patients with psychosis.

Smith SM. Smith SM. J Psychopharmacol. 2008 Mar;22(2 Suppl):63-9. doi: 10.1177/0269881107088438. J Psychopharmacol. 2008. PMID: 18477622 Review.

8

The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patients.

Howes OD, Smith S, Gaughran FP, Amiel SA, Murray RM, Pilowsky LS. Howes OD, et al. J Clin Psychopharmacol. 2006 Dec;26(6):629-31. doi: 10.1097/01.jcp.0000239791.91330.48. J Clin Psychopharmacol. 2006. PMID: 17110820 Free PMC article. Clinical Trial.

9

Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?

Koola MM, Tsapakis EM, Wright P, Smith S, Kerwin Rip RW, Nugent KL, Aitchison KJ. Koola MM, et al. J Psychopharmacol. 2014 Jul;28(7):665-70. doi: 10.1177/0269881114523861. Epub 2014 Mar 4. J Psychopharmacol. 2014. PMID: 24595968 Free PMC article.

10

Comment on Hyperprolactinaemia and antipsychotic therapy in schizophrenia.

Howes OD, Smith S, Aitchison KJ. Howes OD, et al. Curr Med Res Opin. 2004 Oct;20(10):1649. doi: 10.1185/030079904X4941. Curr Med Res Opin. 2004. PMID: 15462698 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,516 results

Search Page

Filters